Healthy Men for Investigational Drug Being Developed for Cancer
Study Reference: 8483-409 1b
Labcorp - Madison
Compensation
Up to
$7725
Recruiting
Study Details
The study drug is an investigational drug being developed for the treatment of cancer. An investigational drug is a drug that has not been approved by the U.S. Food and Drug Administration (FDA).
This type of study is called a radiolabeled study. For this study, the study drug has been specially prepared to contain radiolabeled carbon [14C]. [14C] is a naturally occurring radioactive form of the element carbon. Adding a low dose of radiation to the study drug does not change how the drug works, but helps us to see how the drug appears in the blood, urine, and stool after it is given to you.
Study Period
Study Dates
- Apr. 27 – May 11, 2023
Study involves 1 stay of 7 to 14 nights and administration of investigational medication
- Check-In: April 27
- Minimum Stay: May 4
- Check-Out: May 11
Compensation
- Compensation up to $4,480 to $7,525 may be provided for time and participation
- Receive up to $200 per qualified participant
Eligibility Criteria
- Healthy Men
- Age 18-55
- Body Mass Index between 18-32
Research Location:
Labcorp - Madison
Share with a Friend
Company Information
Labcorp
Clear and confident health care decisions begin with questions. Labcorp is constantly in pursuit of answers. With unparalleled diagnostics and drug development capabilities, Labcorp accelerate innovation and provide insight to improve health and improve lives. Whether you’re a patient, provider, researcher or in the pharmaceutical industry, Labcorp is here for you. Together, Labcorp working to put people first.
Share with a Friend
Other Trials for You
Closed
Featured
Start Date: April 13, 2023 (check-in)
The primary purpose of Part A is to determine the safety and tolerability (side effects) of single doses of the study drug at increasing dose levels. You will be given a single, oral dose of the study drug or a placebo (inactive drug).
Compensation Up to
: $2346
BMI: 18-
32
Volunteer: Healthy
Gender: Man, Woman
Age: 18-
55
Smokers Allowed: No
Closed
Start Date: April 13, 2023 (check-in)
Compensation:
Up to
$2346
Labcorp - Daytona Beach
The primary purpose of Part A is to determine the safety and tolerability (side effects) of single doses of the study drug at increasing dose levels. You will be given a single, oral dose of the study drug or a placebo (inactive drug).
BMI: 18-
32
Volunteer: Healthy
Gender: Man, Woman
Age: 18-
55
Smokers Allowed: No
Not yet recruiting
Featured
CenExel ACT is looking for male and female volunteers for psoriasis study.
Compensation Up to
: $
Gender: Man, Woman
Age: 18-
Smokers Allowed: Not Specified
CenExel ACT - Anaheim
CenExel ACT is looking for male and female volunteers for psoriasis study.
Gender: Man, Woman
Age: 18-
Smokers Allowed: Not Specified
Recruiting
Featured
Start Date: April 24, 2023 (check-in)
Altasciences in Overland Park is looking for healthy elderly volunteers for a clinical research study.
Compensation Minimum
: $8250
BMI: 65-
85
Volunteer: Healthy
Gender: Man, Woman
Age: 65-
85
Smokers Allowed: No
Recruiting
Start Date: April 24, 2023 (check-in)
Compensation:
Minimum
$8250
Altasciences - Overland Park
Altasciences in Overland Park is looking for healthy elderly volunteers for a clinical research study.
BMI: 65-
85